Compare TPL & STE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TPL | STE |
|---|---|---|
| Founded | 1888 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Industrial Specialties |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.6B | 25.9B |
| IPO Year | N/A | 1992 |
| Metric | TPL | STE |
|---|---|---|
| Price | $933.48 | $263.47 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 9 |
| Target Price | ★ $1,050.00 | $268.25 |
| AVG Volume (30 Days) | 128.1K | ★ 674.3K |
| Earning Date | 11-05-2025 | 11-05-2025 |
| Dividend Yield | 0.69% | ★ 0.96% |
| EPS Growth | 6.20 | ★ 59.39 |
| EPS | ★ 20.70 | 6.97 |
| Revenue | $772,395,000.00 | ★ $5,702,415,000.00 |
| Revenue This Year | $8.02 | $9.24 |
| Revenue Next Year | $21.28 | $6.30 |
| P/E Ratio | $44.69 | ★ $37.72 |
| Revenue Growth | ★ 12.48 | 7.08 |
| 52 Week Low | $838.27 | $200.98 |
| 52 Week High | $1,462.78 | $268.60 |
| Indicator | TPL | STE |
|---|---|---|
| Relative Strength Index (RSI) | 51.65 | 59.06 |
| Support Level | $852.57 | $256.68 |
| Resistance Level | $876.55 | $268.60 |
| Average True Range (ATR) | 32.74 | 4.64 |
| MACD | 1.13 | -0.69 |
| Stochastic Oscillator | 46.30 | 65.59 |
Texas Pacific Land Corp is mainly engaged in the sales and leases of land owned, retaining oil and gas royalties, and the overall management of the land owned. It operates its business in two reportable segments; Land and Resource Management and Water Service and Operations. The Land and Resource Management segment focuses on managing surface acres of land and its oil and gas royalty interests, principally concentrated in the Permian Basin. The Water Services and Operations segment encompasses the business of providing full-service water offerings to operators, produced-water treatment, infrastructure development, and disposal solutions. The company generates the majority of its revenue from the Land and Resource Management segment.
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.